Pharmacokinetic profiles of single and repeat doses of lisinopril and enalapril in congestive heart failure

Am J Cardiol. 1992 Oct 8;70(10):151C-153C. doi: 10.1016/0002-9149(92)91378-h.

Authors

D Johnston¹, D Duffin

Affiliation

¹ Department of Therapeutics and Pharmacology, Queen's University of Belfast, Northern Ireland.

PMID: 1329474
DOI: 10.1016/0002-9149(92)91378-h

No abstract available

Publication types

Clinical Trial
Randomized Controlled Trial

MeSH terms

Aged
Angiotensin-Converting Enzyme Inhibitors / administration & dosage
Angiotensin-Converting Enzyme Inhibitors / blood
Angiotensin-Converting Enzyme Inhibitors / pharmacokinetics*
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
Dipeptides / administration & dosage
Dipeptides / blood
Dipeptides / pharmacokinetics*
Dipeptides / therapeutic use
Drug Administration Schedule
Enalapril / administration & dosage
Enalapril / blood
Enalapril / pharmacokinetics*
Enalapril / therapeutic use
Female
Heart Failure / blood
Heart Failure / drug therapy
Heart Failure / metabolism*
Humans
Lisinopril
Male

Substances

Angiotensin-Converting Enzyme Inhibitors
Dipeptides
Enalapril
Lisinopril